c-Maf nuclear oncoprotein is frequently expressed in multiple myeloma

This publication has 9 references indexed in Scilit:

• Genetic risk identifies multiple myeloma patients who do not benefit from autologous stem cell transplantation
  Bone Marrow Transplantation, 2005
• ARK5 is transcriptionally regulated by the Large-MAF family and mediates IGF-1-induced cell invasion in multiple myeloma: ARK5 as a new molecular determinant of malignant multiple myeloma
  Oncogene, 2005
• Immunohistochemistry accurately predicts FGFR3 aberrant expression and t(4;14) in multiple myeloma
  Blood, 2005
• Overexpression of c-maf is a frequent oncogenic event in multiple myeloma that promotes proliferation and pathological interactions with bone marrow stroma
  Cancer Cell, 2004
• Clinical and biologic implications of recurrent genomic aberrations in myeloma
  Blood, 2003
• Oncogenesis of multiple myeloma: 14q32 and 13q chromosomal abnormalities are not randomly distributed, but correlate with natural history, immunological features, and clinical presentation
  Blood, 2002
• Frequent Dysregulation of the c-maf Proto-Oncogene at 16q23 by Translocation to an Ig Locus in Multiple Myeloma
  Blood, 1998
• Frequent Dysregulation of the c-maf Proto-Oncogene at 16q23 by Translocation to an Ig Locus in Multiple Myeloma
  Blood, 1998
• v-maf, a viral oncogene that encodes a "leucine zipper" motif.
  Proceedings of the National Academy of Sciences, 1989